|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
2005-10-3
|
|
pubmed:abstractText |
Epoetin alfa (EPO) and darbepoetin alfa (DARB) are approved for the treatment of chemotherapy-related anemia (CRA) in patients with nonmyeloid malignancies. This study examined dosing and hematologic outcomes with these agents in community oncology clinics.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0300-7995
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
21
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1347-54
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:16197652-Aged,
pubmed-meshheading:16197652-Anemia,
pubmed-meshheading:16197652-Antineoplastic Agents,
pubmed-meshheading:16197652-Blood Transfusion,
pubmed-meshheading:16197652-Erythropoiesis,
pubmed-meshheading:16197652-Erythropoietin,
pubmed-meshheading:16197652-Female,
pubmed-meshheading:16197652-Hematinics,
pubmed-meshheading:16197652-Humans,
pubmed-meshheading:16197652-Male,
pubmed-meshheading:16197652-Middle Aged,
pubmed-meshheading:16197652-Recombinant Proteins,
pubmed-meshheading:16197652-Retrospective Studies
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Retrospective observational study of patients with chemotherapy-related anemia receiving erythropoietic agents.
|
|
pubmed:affiliation |
Thomson Medstat, Washington, DC 20008, USA. tami.mark@thomson.com
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
